Skip to content
Inciteful Med

Getting an Accurate Diagnosis: Testing & Overcoming Misdiagnosis

Last updated:

Myotonic dystrophy is definitively diagnosed using a molecular genetic test to detect specific DNA repeat expansions in the DMPK or CNBP genes. Doctors also use EMG tests, which produce a "dive bomber" sound to confirm muscle stiffness, and check CK blood levels to rule out conditions like fibromyalgia.

Key Takeaways

  • • Genetic testing is the only way to definitively confirm a diagnosis of myotonic dystrophy type 1 (DM1) or type 2 (DM2).
  • • An EMG test can confirm myotonia by producing a characteristic 'dive bomber' sound, but it cannot specify the type of dystrophy.
  • • Myotonic dystrophy is frequently misdiagnosed as fibromyalgia, but the two can be distinguished by EMG results and mildly elevated CK blood levels.
  • • A complete genetic report will detail the specific gene, the repeat size, and any DNA interruptions that might affect disease progression.

Getting a diagnosis for Myotonic Dystrophy can be a long journey, often involving years of searching for answers to “invisible” symptoms like pain and fatigue [1]. Understanding the specific tests used can help you confirm your diagnosis and ensure your medical records are accurate for future care.

The Gold Standard: Genetic Testing

A molecular genetic test is the only way to definitively confirm a diagnosis of Myotonic Dystrophy [2]. These tests look for a specific “repeat expansion”—a section of DNA that repeats many more times than normal [3].

  • DM1 (Type 1): The test looks for a CTG repeat on the DMPK gene (Chromosome 19) [3].
  • DM2 (Type 2): The test looks for a CCTG repeat on the CNBP gene (Chromosome 3) [3].

Testing Methods

Doctors use different tools depending on the size of the repeat they suspect:

  • TP-PCR (Triplet-Primed PCR): A common, fast screening tool that can detect whether an expansion exists [4].
  • Southern Blot: Often used to measure very large repeats (thousands of units), which is particularly important for diagnosing the severe congenital form of DM1 [5][6].

What Should Be in Your Report?

A complete genetic report is your most important piece of medical documentation. It should include:

  1. The Specific Gene: It must clearly state whether the expansion is in the DMPK or CNBP gene [7].
  2. The Repeat Size: A numeric range or specific count of the repeats. In DM1, larger repeat numbers generally correlate with more severe symptoms, though there are exceptions [8][9].
  3. Interruptions: Some reports note if there are “breaks” (interruptions) in the long string of repeats. In DM1, these interruptions can sometimes mean the disease will progress more slowly [10].

If you do not fully understand your report, a Genetic Counselor can help translate these results and guide you on what they mean for your personal prognosis and your family’s testing needs [6].

The EMG: Hearing the “Dive Bomber”

An Electromyography (EMG) test involves inserting small needles into the muscle to record electrical activity [11].

  • The Sound: When the needle is moved or the muscle is contracted, the machine produces a characteristic sound known as a myotonic discharge [12]. This sound is often described as a “dive bomber” because the frequency and volume of the electrical signals wax and wane rapidly [13][14].
  • The Limitation: An EMG proves that you have myotonia (muscle stiffness), but it cannot tell the difference between DM1, DM2, or other rare muscle conditions. Only a genetic test can do that [2].

Overcoming Misdiagnosis

Because Myotonic Dystrophy (especially Type 2) often involves general muscle pain and fatigue, it is frequently misdiagnosed as other conditions [15].

DM2 vs. Fibromyalgia

Many patients with DM2 are initially told they have Fibromyalgia [16].

  • How they differ: Fibromyalgia does not cause myotonia. An EMG will show the “dive bomber” sound in DM2, but will be normal in Fibromyalgia [11][16].
  • CK Levels: A blood test for Creatine Kinase (CK) measures muscle breakdown. In DM2, CK levels are often mildly elevated (“hyper-CK-emia”), whereas they are usually normal in Fibromyalgia [17].

DM vs. Inflammatory Myopathy (Myositis)

Myotonic Dystrophy can sometimes be confused with Myositis (muscle inflammation). While both can cause weakness and elevated CK levels, DM is a genetic condition, while myositis is often an autoimmune issue that requires different treatments [18][19].

CK Levels: DM vs. Other Dystrophies

Condition Typical CK Level
Normal Usually under 200 U/L
DM1 & DM2 Mildly elevated (often 200–1,000 U/L) [17]
Duchenne (DMD) Extremely high (often 10,000–50,000+ U/L) [20]

Knowing your CK level and EMG results can help your doctor differentiate Myotonic Dystrophy from other more common—or more severe—muscle diseases [21].

Frequently Asked Questions

How is myotonic dystrophy definitively diagnosed?
The only way to definitively confirm myotonic dystrophy is through a molecular genetic test. This blood test looks for specific DNA repeat expansions that cause the condition.
What does the 'dive bomber' sound mean on an EMG?
During an EMG test, the "dive bomber" sound is the audio representation of myotonia, or muscle stiffness. While it confirms your muscles have trouble relaxing, it cannot identify the exact type of myotonic dystrophy you have.
Why is myotonic dystrophy sometimes misdiagnosed as fibromyalgia?
Both conditions can cause general muscle pain and fatigue. However, unlike fibromyalgia, myotonic dystrophy causes measurable muscle stiffness and often shows mildly elevated creatine kinase (CK) levels in blood tests.
What information should be included in my genetic test report?
Your report should state the specific gene involved (DMPK or CNBP) and your exact repeat size count. It may also note whether there are any 'interruptions' in the DNA repeats, which can sometimes indicate a slower disease progression.
What do my creatine kinase (CK) levels mean?
Creatine kinase (CK) is an enzyme measured to check for muscle breakdown. In myotonic dystrophy, CK levels are typically mildly elevated, which helps doctors distinguish it from conditions with normal levels like fibromyalgia.

Questions for Your Doctor

  • • What specific genetic test was used (e.g., TP-PCR or Southern blot), and what gene was found to have the expansion?
  • • What was my exact repeat count, and were there any 'interruptions' mentioned in the report that might affect my prognosis?
  • • Did my EMG show characteristic 'myotonic discharges,' and what does that tell us about my muscle function?
  • • How did you rule out other conditions like Fibromyalgia or Myositis given my symptoms?
  • • What was my Creatine Kinase (CK) level, and how does it compare to typical levels for Myotonic Dystrophy?

Questions for You

  • • When I have muscle pain or stiffness, does it improve after I start moving (the 'warm-up' effect)?
  • • Have I had blood tests for muscle enzymes (CK) before, and were they slightly high or very high?
  • • Did the doctor mention my muscles making a specific sound, like a 'dive bomber,' during the needle exam (EMG)?
  • • Was I previously told I had Fibromyalgia, and why did that diagnosis feel like it did or didn't fit?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Myotonic Muscular Dystrophy Type 2 in CT, USA: A Single-Center Experience With 50 Patients.

    Roy B, Wu Q, Whitaker CH, Felice KJ

    Journal of clinical neuromuscular disease 2021; (22(3)):135-146 doi:10.1097/CND.0000000000000340.

    PMID: 33595997
  2. 2

    Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

    Meola G, Cardani R

    Journal of neuromuscular diseases 2015; (2(s2)):S59-S71 doi:10.3233/JND-150088.

    PMID: 27858759
  3. 3

    Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

    LoRusso S, Weiner B, Arnold WD

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2018; (15(4)):872-884 doi:10.1007/s13311-018-00679-z.

    PMID: 30341596
  4. 4

    High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysis.

    Butterfield RJ, Imburgia C, Mayne K, et al.

    Molecular genetics & genomic medicine 2021; (9(4)):e1619 doi:10.1002/mgg3.1619.

    PMID: 33624941
  5. 5

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483
  6. 6

    Myotonic Dystrophy Type 1 Clinical, Electrophysiological and Molecular Characterization: Experience at Tertiary Care Centre.

    Khadilkar S, Jagiasi K, Yadav J, et al.

    The Journal of the Association of Physicians of India 2017; (65(6)):32-37.

    PMID: 28782311
  7. 7

    Myotonic Dystrophies: A Genetic Overview.

    Soltanzadeh P

    Genes 2022; (13(2)) doi:10.3390/genes13020367.

    PMID: 35205411
  8. 8

    Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

    Seifert BA, Reddi HV, Kang BE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(8)):101145 doi:10.1016/j.gim.2024.101145.

    PMID: 38836869
  9. 9

    Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.

    de Pontual L, Tomé S

    International journal of molecular sciences 2022; (23(7)) doi:10.3390/ijms23073477.

    PMID: 35408837
  10. 10

    Robust Preimplantation Genetic Testing Strategy for Myotonic Dystrophy Type 1 by Bidirectional Triplet-Primed Polymerase Chain Reaction Combined With Multi-microsatellite Haplotyping Following Whole-Genome Amplification.

    Lian M, Lee CG, Chong SS

    Frontiers in genetics 2019; (10()):589 doi:10.3389/fgene.2019.00589.

    PMID: 31316546
  11. 11

    Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient.

    Miyashita K, Ii Y, Matsuyama H, et al.

    Internal medicine (Tokyo, Japan) 2023; (62(20)):3027-3031 doi:10.2169/internalmedicine.0425-22.

    PMID: 36792202
  12. 12

    Myotonic disorders: A review article.

    Hahn C, Salajegheh MK

    Iranian journal of neurology 2016; (15(1)):46-53.

    PMID: 27141276
  13. 13

    Acetazolamide-responsive myotonia with a novel Ile239Thr mutation in SCN4A gene: a case report.

    Yadav J, Barnwal R, Kumar Mandal S, Prajapati B

    Annals of medicine and surgery (2012) 2024; (86(2)):1191-1195 doi:10.1097/MS9.0000000000001673.

    PMID: 38333241
  14. 14

    Physiology of Abnormal Muscle Fiber Generators.

    Dumitru D, Nandedkar SD, Barkhaus PE

    Muscle & nerve 2026; (73(1)):7-27 doi:10.1002/mus.70035.

    PMID: 41170697
  15. 15

    Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.

    van Vliet J, Tieleman AA, Verrips A, et al.

    The journal of pain 2018; (19(8)):920-930 doi:10.1016/j.jpain.2018.03.006.

    PMID: 29601898
  16. 16

    Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene.

    Palmio J, Sandell S, Hanna MG, et al.

    Neurology 2017; (88(16)):1520-1527 doi:10.1212/WNL.0000000000003846.

    PMID: 28330959
  17. 17

    Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia.

    Finsterer J, Safoschnik G, Witsch-Baumgartner M

    SAGE open medical case reports 2017; (5()):2050313X17703021 doi:10.1177/2050313X17703021.

    PMID: 28491317
  18. 18

    Potential pitfalls in the differential diagnosis of myositis versus hereditary myopathies.

    Glaubitz S, Zeng R, Hasanov K, et al.

    Clinical and experimental rheumatology 2026; (44(2)):304-312 doi:10.55563/clinexprheumatol/pqmby3.

    PMID: 41678169
  19. 19

    Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion.

    J F, C S, A RF, et al.

    Balkan journal of medical genetics : BJMG 2018; (21(2)):39-43 doi:10.2478/bjmg-2018-0024.

    PMID: 30984523
  20. 20

    Balanced Translocations Involving the DMD Gene as a Cause of Muscular Dystrophy in Female Children: A Description of Three Cases.

    Vorontsova EO, Murtazina A, Zinina E, et al.

    International journal of molecular sciences 2025; (26(19)) doi:10.3390/ijms26199389.

    PMID: 41096657
  21. 21

    Differential Diagnosis between Duchenne Muscular Dystrophy and Limb Girdle Muscular Dystrophy 2a.

    Dobrescu MA, Chelu G, Tache DE, et al.

    Current health sciences journal 2015; (41(4)):385-389 doi:10.12865/CHSJ.41.04.15.

    PMID: 30538847

This page provides educational information about myotonic dystrophy diagnosis and testing. It does not replace professional medical advice from your neurologist or genetic counselor.

Stay up to date

Get notified when new research about Myotonic dystrophy is published.

No spam. Unsubscribe anytime.